---
title: 'CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): 1-year
  effectiveness results for ruptured and unruptured aneurysms'
date: '2024-07-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38991733/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240712181613&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: The Woven EndoBridge (WEB) device is designed to treat wide-necked
  bifurcation aneurysms. The WEB 17 is the latest iteration and can be delivered through
  a 0.017″ microcatheter. The CLEVER study demonstrated that WEB 17 is safe and effective
  for providing protection against bleeding or rebleeding at 1 month and 1 ...'
disable_comments: true
---
BACKGROUND: The Woven EndoBridge (WEB) device is designed to treat wide-necked bifurcation aneurysms. The WEB 17 is the latest iteration and can be delivered through a 0.017″ microcatheter. The CLEVER study demonstrated that WEB 17 is safe and effective for providing protection against bleeding or rebleeding at 1 month and 1 ...